Manulife (Manufacturers Life Insurance)’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-928
| Closed | -$16.1K | – | 3054 |
|
|
2024
Q1 | $16.1K | Sell |
928
-72
| -7% | -$1.25K | ﹤0.01% | 2931 |
|
|
2023
Q4 | $15.6K | Buy |
+1,000
| New | +$15.6K | ﹤0.01% | 2949 |
|
|
2023
Q2 | – | Sell |
-596
| Closed | -$54K | – | 3073 |
|
|
2023
Q1 | $54K | Hold |
596
| – | – | ﹤0.01% | 2851 |
|
|
2022
Q4 | $70.3K | Buy |
+596
| New | +$70.3K | ﹤0.01% | 2871 |
|
|
2022
Q2 | – | Sell |
-585
| Closed | -$90.7K | – | 3164 |
|
|
2022
Q1 | $90.7K | Sell |
585
-116
| -17% | -$18K | ﹤0.01% | 2970 |
|
|
2021
Q4 | $208 | Buy |
701
+8
| +1% | +$2 | ﹤0.01% | 2868 |
|
|
2021
Q3 | $400K | Sell |
693
-48
| -6% | -$27.7K | ﹤0.01% | 2450 |
|
|
2021
Q2 | $336K | Buy |
741
+3
| +0.4% | +$1.36K | ﹤0.01% | 2730 |
|
|
2021
Q1 | $397K | Buy |
738
+260
| +54% | +$140K | ﹤0.01% | 2438 |
|
|
2020
Q4 | $423K | Buy |
478
+58
| +14% | +$51.3K | ﹤0.01% | 2300 |
|
|
2020
Q3 | $266K | Buy |
+420
| New | +$266K | ﹤0.01% | 2382 |
|